Advancing promising technologies and therapies towards clinical application is a complex undertaking. Academic research often lacks easy access to regulatory, therapy development expertise, manufacturing, and healthcare practice, leading to high failure rates. For this reason, the European Joint Programme on Rare Diseases (EJP RD) has initiated a mentoring programme for rare disease researchers.

To facilitate academic collaborations with industry, we provide research services geared towards biotech SMEs and pharmaceutical companies.

We quickly identify scientific & medical expertise and find the capacity to provide access to the latest technologies and core facilities from within our technology platforms.

As part of our mission to support the development of biomedical discoveries up to clinical proof of concept, EATRIS offers learning solutions targeted to the requirements of different audiences. Benefiting from our large network with key opinion leaders in all areas relevant to translational medicine, we will make sure that the courses offer cutting-edge insights.

Addressing regulatory issues is an integral part of bio medicinal development, and their importance will only continue to increase for the foreseeable future. The EATRIS regulatory service and support centre is available to help guide you through this complex world, especially for complex and hybrid products for which clear regulatory guidance may not be available.